@FiercePharma: Zyprexa sales fell off a (patent) cliff , but Lilly still beat analyst forecasts for Q1--Reuters. News | Follow @FiercePharma
> Eli Lilly's ($LLY) first-quarter sales beat its forecast, thanks to milder-than-expected erosion of Zyprexa sales and strong growth of its Cymbalta antidepressant. Report
> Amgen ($AMGN) reported street-beating profits of $1.18 billion, or $1.48 per share, as sales of several products grew by double digits, offsetting ongoing declines in anemia drugs. Article
> India's Ranbaxy Laboratories launched its malaria drug Synriam in its home country, planning to it move into other Asian countries, Africa and South America as well. Item
> Italy's Recordati bought the German rights to 6 over-the-counter drugs from Johnson & Johnson units Cilag and McNeil. Story
> Questcor Pharmaceuticals ($QCOR) first-quarter profits beat analyst estimates on increasing adoption of its multiple sclerosis drug Acthar. More
> ViroPharma lost its court bid to stop a generic version of its antibiotic Vancocin. News
> Botox's active ingredient may help people with the most frequent migraines, but offers little benefit to those whose migraines are less frequent. Report
Biotech News
@FierceBiotech: The Biggest R&D Spenders In Biopharma. Special Report | Follow @FierceBiotech
@JohnCFierce: AVI's retake on IIb DMD data looks to me like a second attempt at a good first impression. Release | Follow @JohnCFierce
@RyanMFierce: Perakslis: FDA plans to open up some of the FDA's liver tox data on >2000 drugs to outside parties. A good example of data sharing. | Follow @RyanMFierce
> Targacept slashes staff by half in wake of PhIII disaster. News
> Sanofi's Lemtrada beats Rebif in head-to-head MS showdown. Story
> Oregano attacks prostate cancer cells in lab experiment. Article
> Scrambling to add new drugs, Big Pharma is paying big premiums for biotechs. Report
Medical Devices News
@FierceMedDev: BioMérieux Q1 2012 sales soar, propelled by China, India. Story | Follow @FierceMedDev
> Medtronic bets IT enhancements will boost revenue. Item
> Expanded use for Edwards' Sapien heart valve faces small FDA delay. More
> Analytical instruments, specialty diagnostics drive Thermo Fisher Q1 sales. Article
Drug Delivery News
@DamianFierce: Tamarisk plans to "turn the industry upside down" with oral insulin platform. News | Follow @DamianFierce
> 'Chemo bomb' nanotechnology effective in halting tumors. Story
> SkyePharma's inhaler takes step toward EMA approval. Article
> Scottish scientists take a page from sci-fi with sonic screwdriver. More
> Australia jumps into life sciences fray with R&D tax credit. Piece
Biomarkers News
> Autism Awareness Month and autism biomarkers. Commentary
> Novo Nordisk, Oxford University seeking inflammation markers. More
> Urine biomarker test for autism on the horizon? Story
> 'Landmark' study splits breast cancer into 10 types. News
And Finally... Leukemia cells have a remembrance of things past. Report